REYON Pharmaceutical Co., Ltd.

KOSE:A102460 Stok Raporu

Piyasa değeri: ₩286.7b

REYON Pharmaceutical Temettü

Temettü kriter kontrolleri 0/6

REYON Pharmaceutical is a dividend paying company with a current yield of 0.96%.

Anahtar bilgiler

1.0%

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisin/a
Gelecekteki Temettü Verimin/a
Temettü Büyümesi-26.4%
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettü₩150.000
Ödeme oranı-2,665%

Son temettü güncellemeleri

Recent updates

REYON Pharmaceutical Co., Ltd.'s (KRX:102460) Shareholders Might Be Looking For Exit

Oct 18
REYON Pharmaceutical Co., Ltd.'s (KRX:102460) Shareholders Might Be Looking For Exit

There May Be Reason For Hope In REYON Pharmaceutical's (KRX:102460) Disappointing Earnings

Mar 31
There May Be Reason For Hope In REYON Pharmaceutical's (KRX:102460) Disappointing Earnings

Consider This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For The 1.6% Dividend

May 08
Consider This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For The 1.6% Dividend

Here's Why REYON Pharmaceutical (KRX:102460) Has A Meaningful Debt Burden

Apr 09
Here's Why REYON Pharmaceutical (KRX:102460) Has A Meaningful Debt Burden

What Percentage Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Shares Do Insiders Own?

Feb 28
What Percentage Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Shares Do Insiders Own?

Read This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For Its Dividend

Jan 20
Read This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For Its Dividend

REYON Pharmaceutical (KRX:102460) Seems To Use Debt Quite Sensibly

Jan 02
REYON Pharmaceutical (KRX:102460) Seems To Use Debt Quite Sensibly

Did REYON Pharmaceutical's (KRX:102460) Share Price Deserve to Gain 50%?

Dec 12
Did REYON Pharmaceutical's (KRX:102460) Share Price Deserve to Gain 50%?

How Much Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Do Insiders Own?

Nov 24
How Much Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Do Insiders Own?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: A102460 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Büyüyen Temettü: A102460 has only been paying a dividend for 5 years, and since then payments have fallen.


Piyasaya Karşı Temettü Getirisi

REYON Pharmaceutical Piyasaya Karşı Temettü Getirisi
A102460 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (A102460)1.0%
Pazarın Alt %25'i (KR)1.2%
Pazarın En İyi %25'i (KR)3.8%
Sektör Ortalaması (Pharmaceuticals)1.0%
Analist tahmini (A102460) (3 yıla kadar)n/a

Önemli Temettü: A102460's dividend (0.96%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.18%).

Yüksek Temettü: A102460's dividend (0.96%) is low compared to the top 25% of dividend payers in the KR market (3.75%).


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: A102460 is paying a dividend but the company is unprofitable.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: A102460 is paying a dividend but the company has no free cash flows.


Güçlü temettü ödeyen şirketleri keşfedin